Acasti pharma inc

Major-Pharmaceuticals

ACST


545, Promenade du Centropolis
Laval , QC H7T 0A3

Executive/
Director

Price

  • Last Close
  • $ 0.51
    $ -0.08 -13.47 %
    Jul 7, 2023
  • 52-Week High/Low
  • $0 - $0
  • YTD
  • 0%

  • Trading Volume
  • 524,346
  • Market Cap Full
  • $ 4.8M
  • Shares Outstanding
  • 9.4M
    Nov 9, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 -4% -40.4% 8.8% 8.5% 22.9% -5% 81.8% -3.2% -8.2% -
Q2 -34.4% -9.2% -2.9% -49.6% 7.8% 4% -6.7% -29.5% 14.1% -
Q3 -14.6% 29.7% 7.6% 118.6% 62% 8% 252.7% -32.6% -2.1% -
Q4 -5.2% -30.2% -29.3% -47.1% 18.8% 55.7% -36.2% -13.6% - -
J F M A M J J A S O N D
2024 - - - - - - - - - - - -
2023 43.7% -28.9% -10.2% -1.3% 18.9% -2.8% -2.1% - - - - -
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    -60%-49%-51%-25%-12%173%-85%282%-60%3%0%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.02 0.13 0.17 - 0.17 0.2 -0.03 -0.09 -3.90
Q2 0.01 0.23 0.14 0.18 0.11 -0.05 -0.01 -0.1 -0.54
Q3 0.01 0.17 0.25 0.20 0.08 -0.06 0.03 -0.11 -0.43
Q4 0.16 0.17 0.31 0.05 0.14 -0.03 -0.09 -0.54 -
A 0.2 0.7 0.9 0.4 0.5 0.1 -0.3 -1 -4.87

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2019 2020 2021 2022 2023
Mar 78.1 - 179.5 44.3 44.6
Jun - 92.5 208.4 44.4 44.6
Sep - 96.9 208.4 44.5 7.4
Dec - 96.9 44.3 44.6 9.4

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - 0.2
Debt – Equity Ratio - - - - 0.2
Interest Coverage 2.7 -4 -12 -6.8 -10.9
Equity multiplier - - 0.2 0.2 1.6